
Sign up to save your podcasts
Or


Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
By JAMA Network3.8
1111 ratings
Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

319 Listeners

503 Listeners

39 Listeners

162 Listeners

58 Listeners

113,219 Listeners

38 Listeners

57,056 Listeners

21 Listeners

13 Listeners

10 Listeners

16 Listeners

20 Listeners

5 Listeners

6 Listeners

46 Listeners

29 Listeners

9 Listeners

91 Listeners

14 Listeners

5 Listeners

5 Listeners

106 Listeners

19 Listeners

15,805 Listeners

2 Listeners

1,201 Listeners